Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.365
Neutral
RSI(14)
55.652
Neutral
STOCH(KDJ)(9,3,3)
31.448
Sell
ATR(14)
3.637
High Vlolatility
CCI(14)
-77.574
Neutral
Williams %R
66.219
Sell
TRIX(12,20)
0.339
Sell
StochRSI(14)
5.251
Oversold
STERIS plc
STE245.060USD
+0.300+0.12%
Close 08/29, 16:00（ET）Quotes delayed by 15 min
24.14BMarket Cap
39.27P/E TTM
TradingKey Stock Score
Financial Health
Valuation Dimension
Forecast
Momentum
Institutional Confidence
Risk Assessment
Peers
TradingKey Stock Score
Currency: USD Updated：2025-08-29Key Insights
The company's fundamentals are relatively healthy.Its valuation is considered fairly valued,and institutional recognition is very high.Over the past 30 days, multiple analysts have rated the company as a Buy.Despite a weak stock market performance, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analysts' Target
Based on
9
analysts
Buy
Current Rating
272.488
Target Price
+11.19%
Upside Space
Disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Company Highlights
StrengthsRisks
STERIS Plc is a provider of products and services that support patient care with an emphasis on infection prevention. Its segments include Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. Its Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. AST segment supports medical device and pharmaceutical manufacturers through a global network of contract sterilization and laboratory testing facilities, and integrated sterilization equipment and control systems. Its Life Sciences segment provides a comprehensive offering of products and services designed to support biopharmaceutical and medical device research and manufacturing facilities, in particular those focused on aseptic manufacturing. Its portfolio includes a full suite of consumable products, equipment maintenance, specialty services, and capital equipment.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 20.35% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 474.27.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 36.04%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 36.04%.
Undervalued
The company’s latest PE is 37.31, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 92.92M shares, decreasing 2.55% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 12.12M shares of this stock.
Financial Health
Currency: USD Updated：2025-08-29The company's current financial score is 7.43, which is higher than the Healthcare Services & Equipment industry's average of 7.15. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 1.48B, representing a year-over-year increase of 32.65%, while its net profit experienced a year-over-year increase of 10678.94%.
Score
Financials
6.61
Related Indicators
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
No Data
Quality of Earnings
7.72
Operational Efficiency
7.50
Growth Potential
6.89
Shareholder Returns
8.44
Valuation Dimension
Currency: USD Updated：2025-08-29The company’s current valuation score is 4.80, which is higher than the Healthcare Services & Equipment industry's average of 2.15. Its current P/E ratio is 37.91, which is 46.92% below the recent high of 55.70 and 0.77% above the recent low of 37.62.
Score
Valuation Dimension
P/E
P/B
P/S
P/CF
Industry Ranking 6/280
No Data
Forecast
Currency: USD Updated：2025-08-29The company’s current earnings forecast score is 8.00, which is higher than the Healthcare Services & Equipment industry's average of 7.66. The average price target for STERIS plc is 280.00, with a high of 295.00 and a low of 231.90.
Score
Support & Resistance
No Data
Analyst Rating
Based on
9
analysts
Buy
Current Rating
272.488
Target Price
+11.19%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
117
Total
7
Median
9
Average
Company name
Ratings
Analysts
STERIS plc
STE
9
Medtronic PLC
MDT
35
Stryker Corp
SYK
33
Abbott Laboratories
ABT
31
Zimmer Biomet Holdings Inc
ZBH
30
Dexcom Inc
DXCM
28
1
2
3
...
24
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
No Data
Disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Momentum
Currency: USD Updated：2025-08-29The company’s current price momentum score is 9.42, which is higher than the Healthcare Services & Equipment industry's average of 7.47. Sideways: Currently, the stock price is trading between the resistance level at 260.78 and the support level at 228.87, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
247.174
Sell
MA10
247.697
Sell
MA20
242.686
Buy
MA50
235.953
Buy
MA100
234.632
Buy
MA200
226.240
Buy
Institutional Confidence
Currency: USD Updated：2025-08-29The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Services & Equipment industry's average of 7.19. The latest institutional shareholding proportion is 94.35%, representing a quarter-over-quarter decrease of 3.92%. The largest institutional shareholder is The Vanguard, holding a total of 12.12M shares, representing 12.31% of shares outstanding, with 2.34% increase in holdings.
Score
Institutional Shareholding
No Data
Shareholder Activity
Name
Shares Held
Chg %
BlackRock Institutional Trust Company, N.A.
MFS Investment Management
State Street Global Advisors (US)
Morgan Stanley Investment Management Ltd. (UK)
Geode Capital Management, L.L.C.
Orbis Investment Management Ltd.
WCM Investment Management
Select Equity Group, L.P.
1
2
Risk Assessment
Currency: USD Updated：2025-08-29The company's beta value is 0.95. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.
Score
Beta vs S&P 500 index
0.96
VaR
+2.54%
240-Day Maximum Drawdown
+17.31%
240-Day Volatility
+24.04%
Return
Best Daily Return
60 days
+6.79%
120 days
+8.52%
5 years
+9.83%
Worst Daily Return
60 days
-2.00%
120 days
-3.97%
5 years
-10.89%
Sharpe Ratio
60 days
+0.24
120 days
+0.54
5 years
+0.35
Risk Assessment
Maximum Drawdown
240 days
+17.31%
3 years
+20.13%
5 years
+36.45%
Return-to-Drawdown Ratio
240 days
+0.01
3 years
+0.79
5 years
+0.14
Skewness
240 days
+1.52
3 years
+0.47
5 years
-0.16
Volatility
Realised Volatility
240 days
+24.04%
5 years
+25.51%
Standardised True Range
240 days
+1.89%
5 years
+1.91%
Downside Risk-Adjusted Return
120 days
+119.28%
240 days
+119.28%
Maximum Daily Upside Volatility
60 days
+17.70%
Maximum Daily Downside Volatility
60 days
+12.47%
Liquidity
Average Turnover Rate
60 days
+0.59%
120 days
+0.63%
5 years
--
Turnover Deviation
20 days
+3.89%
60 days
+11.33%
120 days
+18.23%
Peers
Currency: USD Updated：2025-08-29STERIS plc
STE
7.63 /10
Score
Financial Health
Valuation Dimension
Forecast
Momentum
Institutional Confidence
Risk Assessment
Insulet Corp
PODD
7.89 /10
Score
Financial Health
Valuation Dimension
Forecast
Momentum
Institutional Confidence
Risk Assessment
Merit Medical Systems Inc
MMSI
7.76 /10
Score
Financial Health
Valuation Dimension
Forecast
Momentum
Institutional Confidence
Risk Assessment
Tenet Healthcare Corp
THC
7.66 /10
Score
Financial Health
Valuation Dimension
Forecast
Momentum
Institutional Confidence
Risk Assessment
Brightspring Health Services Inc
BTSG
7.65 /10
Score
Financial Health
Valuation Dimension
Forecast
Momentum
Institutional Confidence
Risk Assessment
Thermo Fisher Scientific Inc
TMO
7.64 /10
Score
Financial Health
Valuation Dimension
Forecast
Momentum
Institutional Confidence
Risk Assessment
View more
The Stock Score data is powered by TradingKey and updated daily. Rating data is sourced from LESG. Please use the data with caution for reference purposes only.
